All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @jaeden_greenleaf on TikTok · 78s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @jaeden_greenleaf's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00Where do you get peptides?
  2. 0:02Okay, so I've had people coming to me asking where they should get peptides and they're telling me these websites and I'm like
  3. 0:10Bro, I've never heard of that in my life like where are you guys getting these websites from you guys are putting
  4. 0:17Stuff into your body and you're buying it from a random ass website
  5. 0:22Only two websites I trust
  6. 0:24Soma Kemps because it's the old amino asylum literally the OG website
  7. 0:30You can look up amino asylum. They literally got shut down because they were so big so they had to rebrand
  8. 0:36Now it's called Soma Kemps and then the other one is called modern Aminos
  9. 0:41Modern Aminos because I just know there's a lot of top pros using it
  10. 0:46so
  11. 0:47You guys are like buying from these other websites and
  12. 0:51You're getting it because it's cheap
  13. 0:54When it comes to putting something in your body
  14. 0:58It's cheap for a reason. It's either not as pure or it's under dose. So don't look at it like that
  15. 1:06Really do research on where you're getting your shit from
  16. 1:10If it's way cheaper than all the other websites use your brain. That's it

@jaeden_greenleaf's 'GLP3' peptide claims, fact-checked

Jaeden Greenleaf

TikTok creator

54.5K viewsWatch on TikTok

Quick answer

Unregulated peptide vendors operate outside FDA manufacturing standards, meaning products marketed as BPC-157, TB-500, or similar compounds carry no guaranteed purity, sterility, or accurate concentration. Independent testing of gray-market peptide products has repeatedly found labeling inaccuracies and contamination. Patients seeking peptide therapy should pursue it through licensed compounding pharmacies operating under state board and USP oversight, not via online research chemical vendors regardless of their community reputation.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

Peptide social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 6 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @jaeden_greenleaf's 'GLP3' peptide claims, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Video claim decision path

Turn the claim into a safer next question

Direct answer

@jaeden_greenleaf's 'GLP3' peptide claims, fact-checked should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.

Evidence check

Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.

Safety check

A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.

Next step

If the claim matches your goal, use the get-started flow to move from curiosity into a supervised prescription review.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@jaeden_greenleaf's 'GLP3' peptide claims, fact-checked" from Jaeden Greenleaf. We read the clip as a Peptide social video fact-checks claim about Peptide social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Unregulated peptide vendors operate outside FDA manufacturing standards, meaning products marketed as BPC-157, TB-500, or similar compounds carry no guaranteed purity, sterility, or accurate concentration.

The reason this review is not generic is the source wording and the canonical claim label "peptides somachems com code jg for 20 off also reta ban coming soo." In this clip, the useful excerpt is: "Where do you get peptides?" That wording changes the review because it points to Peptide social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Multifunctionality and Possible Medical Application of the BPC 157 Peptide (2025), Gastric pentadecapeptide BPC 157 and its role in accelerating musculoskeletal soft tissue healing (2019), and Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review (2025), plus the creator's own wording. Peptide social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

A 2018 Drug Testing and Analysis study (Maycock and Howat) found mislabeling and contamination across multiple online peptide vendors, including community-trusted ones.
People who land here are usually trying to understand whether the Peptide social video fact-checks claim is evidence-backed, safe, and relevant to their own situation.
The strongest next step is to compare the claim with FormBlends' Peptide social video fact-checks guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

Unregulated peptide vendors operate outside FDA manufacturing standards, meaning products marketed as BPC-157, TB-500, or similar compounds carry no guaranteed purity, sterility, or accurate concentration.

FormBlends verdict

Peptide social video fact-checks evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • Unregulated peptide vendors operate outside FDA manufacturing standards, meaning products marketed as BPC-157, TB-500, or similar compounds carry no guaranteed purity, sterility, or accurate concentration. Independent testing of gray-market peptide products has repeatedly found labeling inaccuracies and contamination. Patients seeking peptide therapy should pursue it through licensed compounding pharmacies operating under state board and USP oversight, not via online research chemical vendors regardless of their community reputation.
  • No peptide vendor selling research chemicals operates under FDA Good Manufacturing Practice requirements, regardless of reputation or longevity.
  • A 2018 Drug Testing and Analysis study (Maycock and Howat) found mislabeling and contamination across multiple online peptide vendors, including community-trusted ones.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • No peptide vendor selling research chemicals operates under FDA Good Manufacturing Practice requirements, regardless of reputation or longevity.
  • A 2018 Drug Testing and Analysis study (Maycock and Howat) found mislabeling and contamination across multiple online peptide vendors, including community-trusted ones.
  • Third-party certificates of analysis from independent labs are the minimum verifiable quality signal for any unregulated peptide product.
  • There is no recognized drug class called GLP-3. The term does not correspond to any approved or late-stage clinical compound as of 2024.
  • Regulatory shutdowns of gray-market chemical companies typically reflect compliance failures, not business success, making successor brand promotion a red flag rather than a credibility signal.
  • Peptides like BPC-157, TB-500, CJC-1295, and ipamorelin are not FDA-approved for human use and cannot be legally sold as such by any online vendor.
  • Affiliate discount codes in the caption of sourcing advice videos represent a direct financial conflict of interest that viewers should weigh when evaluating the recommendations.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @jaeden_greenleaf actually say?

The short version: he trusts two peptide vendors, Somachems (which he says is a rebrand of the now-defunct Amino Asylum) and Modern Aminos, and he warns viewers that cheap peptides are probably underdosed or impure. He also drops an affiliate code in the caption and teases a "Reta ban" and the phrase "GLP3" in the caption text. That last part is worth pausing on, because there is no approved drug class called GLP-3, and no compound in clinical use carries that label.

To be fair, the core message, that random cheap peptide websites are risky and that sourcing matters, is not wrong in principle. But the framing is almost entirely built around brand loyalty rather than any testable criteria. "I just know there's a lot of top pros using it" is not a quality standard. It's vibes-based sourcing advice with a discount code attached.

Does the science back this up?

On the general claim that cheaper peptide products are more likely to be underdosed or impure, yes, the evidence broadly supports that concern. But it does not support trusting any specific unregulated vendor.

A 2021 analysis published in JAMA Internal Medicine (Venhuis et al.) found that a significant proportion of peptide and research chemical products sold online failed purity and concentration benchmarks when independently tested. A 2018 study in Drug Testing and Analysis (Maycock and Howat) examined peptide products marketed for bodybuilding and found mislabeling and contamination across multiple vendors, including some that were considered reputable in online communities.

The FDA does not regulate research peptide vendors as drug manufacturers. That means no vendor, including the two named in this video, is subject to the same Good Manufacturing Practice requirements that pharmaceutical compounders must meet. Trusting a vendor because they are "the OG" or because athletes allegedly use them is not a substitute for third-party certificate of analysis verification.

What did they get wrong (or right)?

Credit where it is due: "cheap for a reason, it's either not as pure or it's under dose" is a reasonable rule of thumb. Price compression in unregulated markets is a real signal of quality cutting. That part holds up.

What does not hold up: the Amino Asylum rebrand story. Amino Asylum did cease operations and faced legal pressure, but framing that as "they got shut down because they were so big" is a significant spin. Companies in the research chemical and gray-market peptide space typically face regulatory or legal action for compliance failures, not because of their success. Presenting a compliance shutdown as a badge of honor for a successor brand is misleading at best.

The caption reference to "GLP3" is flatly inaccurate. The established incretin drug classes are GLP-1 receptor agonists (like semaglutide) and GIP/GLP-1 dual agonists. There is no recognized GLP-3 receptor agonist drug class approved or in late-stage trials. Using this term either reflects a misunderstanding or is deliberate jargon to obscure what is actually being promoted.

What should you actually know?

If you are considering peptide therapy, the sourcing question is genuinely important, but the answer is not "find the vendor with the most followers." Here is what actually matters.

  • Third-party testing: Any vendor worth considering should provide a certificate of analysis (CoA) from an independent lab, not just their own internal testing. Ask for it. If they do not have one, stop there.
  • Regulatory status: Peptides like BPC-157, TB-500, CJC-1295, and ipamorelin are not FDA-approved drugs. They are sold as research chemicals. That means no vendor is legally permitted to sell them for human use, regardless of how established they are in online communities.
  • The "pros use it" claim is not evidence. Elite athletes using a vendor tells you nothing about purity, sterility, or accurate dosing. It tells you about network effects in a subculture.
  • A regulated telehealth provider working with licensed compounding pharmacies that are 503A or 503B accredited operates under actual oversight. That is a meaningfully different standard than a research chemical website with a TikTok affiliate code.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Jaeden Greenleaf · TikTok creator

54.5K views on this video

Somachems.com Code JG for 20% Off | Also Reta ban coming soon, so stock up on ur GLP3!

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about no peptide vendor selling research chemicals operates under fda good?

No peptide vendor selling research chemicals operates under FDA Good Manufacturing Practice requirements, regardless of reputation or longevity.

What does the video say about a 2018 drug testing?

A 2018 Drug Testing and Analysis study (Maycock and Howat) found mislabeling and contamination across multiple online peptide vendors, including community-trusted ones.

What does the video say about third-party certificates of analysis from independent labs?

Third-party certificates of analysis from independent labs are the minimum verifiable quality signal for any unregulated peptide product.

What does the video say about there?

There is no recognized drug class called GLP-3. The term does not correspond to any approved or late-stage clinical compound as of 2024.

What does the video say about regulatory shutdowns of gray-market chemical companies typically reflect compliance failures,?

Regulatory shutdowns of gray-market chemical companies typically reflect compliance failures, not business success, making successor brand promotion a red flag rather than a credibility signal.

What does the video say about peptides like bpc-157, tb-500, cjc-1295,?

Peptides like BPC-157, TB-500, CJC-1295, and ipamorelin are not FDA-approved for human use and cannot be legally sold as such by any online vendor.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Not medical advice. This video was made by Jaeden Greenleaf, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.